UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 60

Sortiert nach

Duodenal obstruction secondary to a metastasis from an adenocarcinoma of the cecum : A case report

The American journal of gastroenterology, 1997-06, Vol.92 (6), p.1051-1052

1997

Volltextzugriff (PDF)

Brain metastases from colorectal carcinoma

Tumori, 2001-09, Vol.87 (5), p.332-334

2001

Volltextzugriff (PDF)

SEOM clinical guidelines for the treatment of head and neck cancer (2020)

Clinical & translational oncology, 2021-05, Vol.23 (5), p.913-921

2021

Volltextzugriff (PDF)

Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS)

Annals of oncology, 2017-12, Vol.28 (12), p.2994-2999

2017

Volltextzugriff (PDF)

Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer

Journal of clinical oncology, 2005-12, Vol.23 (34), p.8636-8645

2005

Volltextzugriff (PDF)

Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial

Clinical & translational oncology, 2021-04, Vol.23 (4), p.764-772

2021

Volltextzugriff (PDF)

Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1)

Oral oncology, 2017-07, Vol.70, p.58-64

2017

Volltextzugriff (PDF)

Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head and neck cancer unfit for platinum derivatives. The phase II, PANTERA/TTCC-2010-06 study

Clinical & translational oncology, 2021-08, Vol.23 (8), p.1666-1677

2021

Volltextzugriff (PDF)

Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) Study

Annals of oncology, 2010-07, Vol.21 (7), p.1552-1557

2010

Volltextzugriff (PDF)

GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)

British journal of cancer, 2017-09, Vol.117 (6), p.767-774

2017

Volltextzugriff (PDF)

Activity of weekly paclitaxel−cetuximab chemotherapy in unselected patients with recurrent/metastatic head and neck squamous cell carcinoma: prognostic factors

Clinical & translational oncology, 2017-06, Vol.19 (6), p.769-776

2017

Volltextzugriff (PDF)

1489MO A phase Ib/II study of selinexor as single agent and in combination with imatinib in patients with advanced gastrointestinal stromal tumor (GIST): SeliGIST/GEIS-41 trial

Annals of oncology, 2022-09, Vol.33, p.S1228

2022

Volltextzugriff (PDF)

SEOM clinical guideline in nasopharynx cancer (2017)

Clinical & translational oncology, 2018-01, Vol.20 (1), p.84-88

2018

Volltextzugriff (PDF)

A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma : A study by the Spanish group for research on sarcomas

Cancer, 2005-10, Vol.104 (8), p.1706-1712

2005

Volltextzugriff (PDF)

Efficacy and safety of vandetanib for patients with advanced and progressive medullary thyroid cancer (MTC) as systemic treatment beyond first-line therapy

Annals of oncology, 2018-10, Vol.29, p.viii476-viii476

2018

Volltextzugriff (PDF)

1922P Immunosarc II master trial: phase II of sunitinib and nivolumab in vascular sarcomas cohort - A GEIS, ISG and UCL study

Annals of oncology, 2023-10, Vol.34, p.S1034-S1034

2023

Volltextzugriff (PDF)

Correction to: SEOM clinical guidelines for the treatment of head and neck cancer (2020)

Clinical & translational oncology, 2021-05, Vol.23 (5), p.1001-1001

2021

Volltextzugriff (PDF)

723O Cabozantinib plus atezolizumab in advanced and progressive neoplasms of the endocrine system: A multi-cohort basket phase II trial (CABATEN/GETNE-T1914)

Annals of oncology, 2023-10, Vol.34, p.S498-S498

2023

Volltextzugriff (PDF)

Epidemiological characteristics of a Spanish cohort of patients diagnosed with squamous cell carcinoma of head and neck: distribution of risk factors by tumor location

Clinical & translational oncology, 2016-11, Vol.18 (11), p.1114-1122

2016

Volltextzugriff (PDF)

2220P MOLTHY project (TTCC-2020-02): A Spanish observational study for MOLecular characterization of THYroid carcinoma

Annals of oncology, 2023-10, Vol.34, p.S1144-S1144

2023

Volltextzugriff (PDF)

Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment

British journal of cancer, 2010-06, Vol.102 (12), p.1687-1691

2010

Volltextzugriff (PDF)

The importance of comorbidity assessment in patients with oral squamous cell carcinoma (OSCC): Could the adult comorbidity evaluation – 27 (ACE-27) provide an additional information?

Annals of oncology, 2018-10, Vol.29, p.viii393-viii393

2018

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(60)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(27)
Science & Technology
(27)
Oncology
(26)
Humans
(25)
Middle Aged
(19)
Adult
(18)
Male
(18)
Female
(17)
Aged
(16)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Medicine
(8)
Medicine & Public Health
(8)
Tumors
(8)
Aged, 80 And Over
(6)
Deoxycytidine - Analogs & Derivatives
(6)
Head And Neck Cancer
(6)
Treatment Outcome
(6)
Deoxycytidine - Administration & Dosage
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study

Duodenal obstruction secondary to a metastasis from an adenocarcinoma of the cecum : A case report

Brain metastases from colorectal carcinoma

A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer

SEOM clinical guidelines for the treatment of head and neck cancer (2020)

Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS)

Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer

Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial

Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1)

Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head and neck cancer unfit for platinum derivatives. The phase II, PANTERA/TTCC-2010-06 study

Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) Study

GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)

Activity of weekly paclitaxel−cetuximab chemotherapy in unselected patients with recurrent/metastatic head and neck squamous cell carcinoma: prognostic factors

1489MO A phase Ib/II study of selinexor as single agent and in combination with imatinib in patients with advanced gastrointestinal stromal tumor (GIST): SeliGIST/GEIS-41 trial

SEOM clinical guideline in nasopharynx cancer (2017)

A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma : A study by the Spanish group for research on sarcomas

Efficacy and safety of vandetanib for patients with advanced and progressive medullary thyroid cancer (MTC) as systemic treatment beyond first-line therapy

1922P Immunosarc II master trial: phase II of sunitinib and nivolumab in vascular sarcomas cohort - A GEIS, ISG and UCL study

Correction to: SEOM clinical guidelines for the treatment of head and neck cancer (2020)

723O Cabozantinib plus atezolizumab in advanced and progressive neoplasms of the endocrine system: A multi-cohort basket phase II trial (CABATEN/GETNE-T1914)

Epidemiological characteristics of a Spanish cohort of patients diagnosed with squamous cell carcinoma of head and neck: distribution of risk factors by tumor location

2220P MOLTHY project (TTCC-2020-02): A Spanish observational study for MOLecular characterization of THYroid carcinoma

Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment

The importance of comorbidity assessment in patients with oral squamous cell carcinoma (OSCC): Could the adult comorbidity evaluation – 27 (ACE-27) provide an additional information?

678P Real-world evidence of first-line cetuximab (CX) plus paclitaxel (PX) in recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN)

Suchergebnisse filtern